Oncology and tumour-directed therapies
Research activity spans colorectal cancer, rectal cancer, colon cancer, pancreatic ductal adenocarcinoma, breast cancer, basal cell carcinoma, and other cutaneous malignancies, with interest in both local and systemic treatment strategies.
- Electrochemotherapy and electroporation
- Immunotherapy and PD-1 inhibitor approaches
- Intratumoral and neoadjuvant cancer treatment
- Tumour downstaging and local disease control
Additional work includes flu vaccine-based local treatment concepts, optical coherence tomography assessment of skin tumours, and treatment-focused studies in dMMR colon cancer and pMMR colorectal cancer.
Perioperative care and pain management
The sponsor supports studies in postoperative pain, caesarean section analgesia, breast surgery pain control, and abdominal surgery support, including interest in intrathecal morphine and regional block techniques.
- Intertransverse process block
- ITP block for breast cancer surgery
- Intrathecal morphine in caesarean section
- Preoperative anxiety and perioperative symptom control
Research also covers autonomic responses around surgery and support for patients undergoing major abdominal procedures.
Infectious complications and abdominal inflammation
Clinical interest includes peritonitis, pouchitis, and infection prevention in high-risk surgical and medical settings, with attention to antibacterial and immune-modulating treatment concepts.
- Multiquadrant peritonitis
- Pouchitis after restorative ileal pouch surgery
- Hemodialysis-related infection and bloodstream infection
- Prophylactic antibiotic treatment
Studies also address sepsis in patients with renal failure, reflecting interest in infection-related morbidity across surgical and chronic care pathways.
Hematology and immune-mediated disorders
Research activity includes blood cancer, polycythemia vera, myeloproliferative neoplasms, and immune thrombocytopenia, with attention to inflammatory and haematologic markers.
- Polycythemia and myeloproliferative neoplasms
- Blood cancer
- Immune and inflammatory markers
- ITP and related pain management contexts
There is also interest in iron deficiency in oncology patients and in therapies linked to immune regulation.
Supportive care and symptom-focused interventions
The trial portfolio includes studies on iron supplementation, preoperative stress, and treatment-related symptom relief, with outcomes relevant to physical function, comfort, and recovery.
- Iron deficiency in cancer care
- Preoperative anxiety
- Physical capacity after treatment
- Safety and tolerability of supportive interventions
These studies extend across oncology, surgical recovery, and chronic disease settings, including patients with renal failure and abdominal cancer.
